Company NewCardio, Inc. Other OTC
Equities
NWCI
US65106G1004
Advanced Medical Equipment & Technology
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cardiac Diagnosis
100.0
%
| 0 | nan % | 0 | 100.0 % | +∞% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | +∞% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jess Emery Jones
CEO | Chief Executive Officer | 45 | 30/11/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jess Emery Jones
CEO | Chief Executive Officer | 45 | 30/11/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,295 | 0 | 0 | 75.73 % |
Stock B | 1 | 33,210,807 | 25,150,108 ( 75.73 %) | 62,500 ( 0.1882 %) | |
Stock C | 0 | 12,116 | 0 | 0 |
Company contact information
NewCardio, Inc.
103 Carnegie Center Suite 300
08540-6235, Princeton
+
![address NewCardio, Inc.(NWCI)](https://cdn.zonebourse.com/static/address/10554521.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |